Clinical Trials

Showing trials with last updates posted in 2021.

NCT04062617 | COMPLETED
929 participants

Cmplications of ERCP

Study Type:
OBSERVATIONAL
Last Updated:
2021-05-27
Start Date:
2018-08-01
Completion:
2019-08-30
Conditions
  • Complication of ERCP
No Results Yet
NCT03850327 | COMPLETED | NA
48 participants

BIO|CONCEPT.BIOMONITOR III

Study Type:
INTERVENTIONAL
Last Updated:
2021-05-27
Start Date:
2019-03-08
Completion:
2019-10-06
Conditions
  • Atrial Fibrillation
  • Syncope
  • Tachyarrhythmia
Interventions
  • DEVICE
No Results Yet
NCT03467061 | COMPLETED | NA
101 participants

The Effect of Dietary Nitrate on the Oral Microbiome

Study Type:
INTERVENTIONAL
Last Updated:
2021-05-27
Start Date:
2018-01-10
Completion:
2021-05-06
Conditions
  • Cardiovascular Health
  • Identify Oral Bacteria Responsible for Nitrate Reduction
Interventions
  • DIETARY_SUPPLEMENT
  • OTHER
No Results Yet
NCT03388918 | COMPLETED | NA
140 participants

Future Patient - Telerehabilitation of Heart Failure Patients

Study Type:
INTERVENTIONAL
Last Updated:
2021-05-27
Start Date:
2016-12-21
Completion:
2019-08-01
Conditions
  • Heart Failure NYHA Class I
  • Heart Failure NYHA Class II
  • Heart Failure NYHA Class III
  • Heart Failure NYHA Class IV
  • Acute Decompensated Heart Failure
Interventions
  • DEVICE
No Results Yet
NCT02965378 | COMPLETED | PHASE2/PHASE3
43 participants

Lung-MAP: AZD4547 as Second-Line Therapy in Treating FGFR Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2021-05-27
Start Date:
2014-10-31
Completion:
2017-01-31
Conditions
  • FGFR1 Gene Amplification
  • FGFR1 Gene Mutation
  • FGFR2 Gene Amplification
  • FGFR2 Gene Mutation
  • FGFR3 Gene Amplification
  • FGFR3 Gene Mutation
  • Recurrent Squamous Cell Lung Carcinoma
  • Stage IV Squamous Cell Lung Carcinoma AJCC v7
Interventions
  • DRUG
  • OTHER
NCT02785939 | COMPLETED | PHASE2/PHASE3
53 participants

Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2021-05-27
Start Date:
2014-09-30
Completion:
2017-06-30
Conditions
  • CCND1 Gene Amplification
  • CCND2 Gene Amplification
  • CCND3 Gene Amplification
  • CDK4 Gene Amplification
  • Recurrent Squamous Cell Lung Carcinoma
  • Stage IV Squamous Cell Lung Carcinoma AJCC v7
Interventions
  • DRUG
  • OTHER
Previous
Sorted by latest updates
Next
Showing 40 trials per page